Mitigating Veno-occlusive Disease Risk in Patients Treated for Relapsed/Refractory B-cell Precursor ALL

Veno-occlusive disease (VOD) is a life-threatening condition associated with treatment of relapsed/refractory B-cell precursor acute lymphoblastic leukemia (R/R ALL). Early recognition and management are paramount to recovery. This self-directed education was designed for diverse members of the interdisciplinary care team who treat or may encounter patients with R/R ALL who are at risk for VOD. Expert commentary from Partow Kebriaei, MD, provides answers to common questions faced by clinicians when diagnosing and managing VOD.
Educational Partner: Academy for Continued Healthcare Learning (ACHL)

Medium: Online Module

Commercial Support: Support for this activity has been provided through an educational grant from Pfizer Inc.

Target Audience

This activity is intended for hematologists/oncologists, oncology nurses, and others on the multidisciplinary healthcare team who are involved in the care of patients with ALL.

Learning Objectives

After completing this activity, participants will be able to:

  • Create optimal relapsed/(R/R ALL treatment plans in terms of treatment selection, sequencing, and dosing while incorporating patient point-of-care (in-patient versus out-patient);
  • Incorporate strategies and tools to mitigate and manage veno-occlusive disease risk in patients with R/R ALL proceeding to HSCT;
  • Outline tactics to facilitate interdisciplinary communication and decision-making.
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
Laurie Novoryta
CME Coordinator Contact Email: 
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
Activity opens: 
Activity expires: 
  Partow Kebriaei, MD
  The University of Texas
  MD Anderson Cancer Center
  Houston, TX


Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University Of Chicago Pritzker School Of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professions Credit
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
REGISTRATION: To view this activity, you will need to visit ACHL's website.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!
Please login or create an account to proceed.